Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials.

Epilepsia·2026
Same author

Feature library for behavioural characterization of early and late seizures in an experimental model of post-traumatic epilepsy.

Journal of neuroscience methods·2026
Same author

Beneficial Effects of Intravenous Immunoglobulin Treatment in a Mouse Preclinical Model of Severe Traumatic Brain Injury.

Journal of neurotrauma·2025
Same author

How to report neurotechnology and artificial intelligence studies in epilepsy: Peer-review-inspired recommendations.

Epilepsia open·2025
Same author

WONOEP XVII appraisal: The immunopathogenesis of epilepsy.

Epilepsia·2025
Same author

Erratum to "Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions" [Pharmacological Reviews 77 (2025) 100080].

Pharmacological reviews·2025
Same journal

Responsible use of artificial intelligence in peer-reviewed publications in epilepsy.

Epilepsia·2026
Same journal

Altered autonomic balance drives the increase in cardiac output and arterial pressure during convulsive seizures in nonanesthetized sheep.

Epilepsia·2026
Same journal

Diagnostic yield and copy number variants findings in 219 adult patients with developmental and epileptic encephalopathy.

Epilepsia·2026
Same journal

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Epilepsia·2026
Same journal

Electrocardiography characteristics and long-term mortality in people with epilepsy from a resource-poor community.

Epilepsia·2026
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Epilepsy therapy development: technical and methodologic issues in studies with animal models.

Aristea S Galanopoulou1, Merab Kokaia, Jeffrey A Loeb

  • 1Laboratory of Developmental Epilepsy, Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461, USA. aristea.galanopoulou@einstein.yu.edu

Epilepsia
|August 6, 2013
PubMed
Summary
This summary is machine-generated.

Improving preclinical epilepsy research is crucial for developing new seizure treatments. This study proposes enhanced methods and reporting for animal models to increase reliability and predict human efficacy for epilepsy therapies.

Keywords:
InfrastructureNonpharmacological treatmentPharmacokineticsRegulatory requirementsTolerabilityVideo-electroencephalography

More Related Videos

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Related Experiment Videos

Last Updated: May 9, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
09:29

Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

Published on: August 17, 2021

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Area of Science:

  • Translational neuroscience
  • Epilepsy research
  • Preclinical drug development

Background:

  • Developing novel epilepsy treatments is challenging due to incomplete understanding of epilepsy causes and progression.
  • Predicting human treatment efficacy and tolerability from preclinical models remains difficult.

Purpose of the Study:

  • To propose standardized methodologic and reporting practices for early-stage preclinical studies of epilepsy therapies.
  • To enhance the reliability and uniformity of data from animal seizure and epilepsy models.

Main Methods:

  • Summarized discussions and proposals from the American Epilepsy Society and International League Against Epilepsy Translational Workshop.
  • Focused on improving study design, reporting, covariate analysis (species, age, sex), target validation, exposure assessment, clinically relevant protocols, video-electroencephalography (EEG) use, and outcome measures beyond seizure activity.
  • Considered regulatory requirements for human clinical testing.

Main Results:

  • Identified key areas for improving preclinical epilepsy research rigor.
  • Proposed specific practices for study design, data collection, and outcome assessment.
  • Highlighted the need for infrastructure to support academic researchers in epilepsy therapy development.

Conclusions:

  • Implementing proposed rigorous practices will enhance the quality and predictive value of preclinical epilepsy studies.
  • Standardization is essential for advancing the development of new anti-seizure and anti-epilepsy therapies.
  • Infrastructure support is needed to facilitate the adoption of these improved practices by academic researchers.